Focused Compounding Nominates Jacob McDonough (The Guy Who
DALLAS, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Focused Compounding is pleased to announce the nomination of Jacob McDonough to their board slate for Parks!...
Source: globenewswire.com
📰 Capital Allocation News
Page 75 - Capital Allocation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Capital Allocation. Real-time updates on events, politics, business and more.
Focused Compounding Nominates Jacob McDonough (The Guy Who LITERALLY Wrote the Book on Capital Allocation) For Parks! America's June 6th Annual Meeting -January 29, 2024 at 09:25 am EST
DALLAS, Jan. 29, 2024 -- Focused Compounding is pleased to announce the nomination of Jacob McDonough to their board slate for Parks! America Inc’s June 6th annual meeting. Mr. McDonough...
Source: marketscreener.com
Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors
Charles River Laboratories International, Inc. today announced the appointment of Reshema Kemps-Polanco, Executive Vice President and Chief Commercial Officer, Novartis US, to its Board of...
United States Reshema Kemps Polanco Jamesc Foster Reshema Kemp Polanco Charles River Laboratories International Inc Healthcare Leadership Council
Source: marketscreener.com
Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors
24.01.2024 - Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of Reshema Kemps-Polanco, Executive Vice President and Chief Commercial Officer, Novartis US, to its Board of Directors. Ms. Kemps-Polanco has extensive ... Seite 1
Reshema Kemps Polanco Jamesc Foster Reshema Kemp Polanco Janssen Pharmaceuticals Puerto Rico Charles River Laboratories International Inc Charles River Laboratories International
Source: wallstreet-online.de
ExxonMobil's Acquisition of Pioneer and Climate Change
ExxonMobils acquisition of Pioneer gives it a huge footprint in the Permian Base. It has both economic and climate benefits. Still, there are critics.
Source: forbes.com
Low rates corrupt investing, and the US hasn't had a free market in money since the 1990s, billionaire investor Howard Marks says
"Maybe we have a new version of Lord Acton's law: easy money corrupts, and really easy money corrupts absolutely."
Charlie Munger Howard Marks Federal Reserve Silicon Valley Bank Great Financial Crisis Oaktree Capital
Source: yahoo.com
NBPE Announces 1H 2024 Dividend
THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS NBPE...
Source: marketscreener.com
Acuity Brands Reports Fiscal 2024 First-Quarter Results
Strong Execution Delivering Margin Expansion and EPS GrowthDelivered Net Sales of $935M, a 6% Decline Compared to the Prior YearGrew Operating Profit to $133M, up 22% Over the Prior Year; Adjusted...
United States Neil Ashe April Appling Charlotte Mclaughlin Intelligent Spaces Group Exchange Commission
Source: marketscreener.com
Join Canada's Warren Buffett on his acquisition gravy train
Whether managing a business or an investment portfolio, success boils down to the effectiveness of capital allocation. Allocating capital to high-return opportunities is the engine that powers “compounding” – the money-making magic that over time creates vast fortunes and was famously described by Albert Einstein as the “eighth wonder of the world”.
Source: yahoo.com
HARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2023 NET PRODUCT REVENUE INCREASES MORE THAN 30 PERCENT; PROVIDES 2024 NET PRODUCT REVENUE GUIDANCE
/PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today reported preliminary, unaudited fourth quarter and full year 2023 net product revenue...
United States Luis Sanay Jeffreym Dayno Drug Administration Paragon Biosciences Zynerba Pharmaceuticals
Source: prnewswire.com